Stay updated with breaking news from Initial Statements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
$10.50 Per Share All-Cash Transaction Represents a Significant Premium for Tabula Rasa Stockholders Combination of Two Highly Complementary Companies to Benefit Patients, Providers and Payers with...
Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ --...
SKYCLARYS® recently approved in US as the only treatment indicated for patients with Friedreich’s ataxia Proposed acquisition represents meaningful step…
Biogen to Acquire Reata Pharmaceuticals SKYCLARYS® recently approved in US as the only treatment indicated for patients with Friedreich's...
Heritage-Crystal Clean shareholders to receive $45.50 per share in cash